There is a lot of discussion about pharmaceutical companies‚ intellectual property‚ and the global AIDS epidemic. Do pharmaceutical companies have a responsibility to distribute drugs for free or low cost in developing countries? Why is intellectual property such a big deal? What impact would South Africa’s decision to levy duties on drugs in the country have on the international distribution of drugs? Was the change that provided patent protection for pharmaceutical companies an appropriate change
Premium Generic drug Developing country Developed country
Beximco Pharmaceutical Ltd is the manufacturer and marketer of pharmaceutical product under chemical divisions of Beximco Group. Beximco Pharmaceuticals is one of the leading pharmaceutical companies in Bangladesh. It also is one of the biggest suppliers of pharmaceutical product of any Bangladeshi based company. BPL is the first Bangladeshi company to supply pharmaceutical product to Riffles Hospital the most prestigious hospital of Singapore. The study has been carried out with the following objectives:
Premium Marketing Pharmaceutical industry Pharmacology
Cooper Pharmaceuticals Inc BMKT 436: Sales and Sales Management Shaye Murphy 10/12/2013 Executive Summary Goals Cooper Pharmaceuticals Inc (CPI) is a major manufacturer for the dental and medical practices in the United States. Their ultimate goal is to remain the largest drug manufacturer and meet the sales quotas. CPI has strong ethical policies that they want to keep that have shaped the companies’ reputation. In hiring Bob Marsh‚ they were meeting their goals
Premium Sales Customer service Marketing
OVERVIEW – INDIAN PHARMACEUTICALINDUSTRY | | 1.1 | Current Scenario | 6 | 1.2 | Major Pharmaceutical Companies | 10 | 1.3 | Government Initiatives | 12 | 1.4 | Oncology Segment | 15 | | LUNG CANCER | | 2.1 | World Scenario | 21 | 2.2 | Indian Scenario | 22 | 2.3 | About Lung Cancer | 30 | 2.4 | Stages of Lung Cancer | 36 | 2.5 | Causes of Lung Cancer | 46 | | LONG LIFE PHARMACEUTICALS PVT. LTD. | | 3.1 | Vision and Mission | 48 | 3.2 | Board of Directors | 49 | 3.3
Premium Cancer Lung cancer Oncology
Safety Implementations Table of Contents 1 Abstract 4 2 Introduction 5 3 Safe Drug Development Process in Pharmaceutical Companies 6 4 Pharmaceutical Unit Operation Safety Measures 10 4.1 Weighing and dispensing 10 4.2 Charging and discharging 10 4.3 Liquid separations 10 4.4 Filtration 11 4.5 Compounding 11 4.6 Drying 11 5 Biosafety Levels 12 5.1 Level 1 12 5.2 Level 2 12 5.3 Level 3 12 5.4 Level 4 13 6 Personal Protective Equipment 13 6.1 What is PPE? 13 6.2 OSHA Standards
Premium Occupational safety and health Personal protective equipment Pharmaceutical industry
Pharmaceutical Marketing Merck “Merck has gone beyond developing and selling prescription pharmaceuticals. It formed joint ventures in 1989 with Johnson & Johnson to sell over the-counter pharmaceuticals; in 1991 with DuPont to expand basic research‚ and in 2000 with Scherigng-Plough to develop and market new prescriptions medicines. In 1997‚ Merck and Rhone-Poulenc S.A. (now Sanofi-Aventis S.A.) combined animal health and poultry genetics business to form Merial Limited‚ a fully integrated
Premium Pharmaceutical industry Pharmacology Clinical trial
cardiovascular disorders‚ antibiotics such as Cefzil‚ antidiabetics such as Glucophage‚ and the anti-clotting medication‚ Plavix. To continue to focus on pharmaceuticals‚ in the early years of 2000-2002‚ the company divested many of their non-pharmaceutical divisions‚ such as Clairol and the Mead-Johnson Nutritional division‚ and purchased DuPont Pharmaceuticals as well as an almost 20% share of ImClone Systems‚ which was getting ready to release a new anti-cancer drug‚ Erbitux (SEC eyes Bristol-Myers‚ 2002)
Premium Revenue Marketing Inventory
All. Loyola of Los Angeles Law Review‚ 20(421). Retrieved November 18‚ 2012‚ from http://digitalcommons.lmu.edu/cgi/viewcontent.cgi?article=1496&context=llr Lum‚ T. (2012). The Republic of the Philippines and U.S. Interests. Congressional Research Service‚ 14. Retrieved November 17‚ 2012‚ from http://www.fas.org/sgp/crs/row/RL33233.pdf Pattugalan‚ G. R. (1999). A Review of Philippine Foreign Policy Under the Ramos Administration. Kasarinlan: Philippine Journal of Third World Studies‚ 14(3). Retrieved
Premium United States Philippines United States Army
Presentation on Beximco Pharmaceuticals Name of the presenters ~ Faisal Bin Kamal 2009-3-10-057 2010-1-10-145 2010-1-10-149 2010-1-40-052 ~ Quazi Aritra Reyan ~ Md. Nayeem Hossain ~ Tahrim Shahriar Background of the Company Beximco Pharmaceuticals (BPL) is a leading edge pharmaceutical company based in Dhaka‚ Bangladesh. BPL started its operation in 1980 and now have grown to become nation’s one of the leading pharmaceutical companies. ~ BPL supplies more than 10% of country’s
Premium Pharmaceutical industry Tax Balance sheet
Chapter 3 Closing Case: The Pharmaceutical Industry Historically‚ the pharmaceutical industry has been a profitable one. Between 2002 and 2006 the average rate of return on invested capital (ROIC) for firms in the industry was 16.45 percent. Put differently‚ for every dollar of capital invested in the industry‚ the average pharmaceutical firm generated 16.45 cents of profit. This compares with an average return on invested capital of 12.76 percent for firms in the computer hardware industry‚
Premium Pharmacology Generic drug Pharmaceutical industry